LLMpediaThe first transparent, open encyclopedia generated by LLMs

Ovarian Cancer Research Alliance

Generated by GPT-5-mini
Note: This article was automatically generated by a large language model (LLM) from purely parametric knowledge (no retrieval). It may contain inaccuracies or hallucinations. This encyclopedia is part of a research project currently under review.
Article Genealogy
Expansion Funnel Raw 99 → Dedup 0 → NER 0 → Enqueued 0
1. Extracted99
2. After dedup0 (None)
3. After NER0 ()
4. Enqueued0 ()
Ovarian Cancer Research Alliance
NameOvarian Cancer Research Alliance
Formation1996
TypeNonprofit
HeadquartersNew York City
Region servedUnited States

Ovarian Cancer Research Alliance is a nonprofit organization dedicated to advancing research, advocacy, and patient support for ovarian cancer. Founded through the merger of advocacy groups, the organization coordinates scientific funding, public outreach, and policy efforts to improve prevention, diagnosis, treatment, and survivorship for people affected by ovarian cancer. It operates through partnerships with medical centers, research institutions, philanthropic foundations, and public officials to translate research into clinical practice.

History

The organization traces origins to grassroots movements and established groups such as the American Cancer Society, National Institutes of Health, Susan G. Komen for the Cure, Leukemia & Lymphoma Society, and regional coalitions that arose in the late 20th century. Early collaborations involved clinical centers like Memorial Sloan Kettering Cancer Center, Mayo Clinic, Johns Hopkins Hospital, Massachusetts General Hospital, and MD Anderson Cancer Center, and research networks including the National Cancer Institute and the European Institute of Oncology. Key influences and allies over time included philanthropic entities such as the Gates Foundation, Ford Foundation, Howard Hughes Medical Institute, Rockefeller Foundation, and academic institutions like Harvard Medical School, Stanford University School of Medicine, Yale School of Medicine, and Columbia University Irving Medical Center. The organization engaged with advocacy figures and survivorship initiatives linked to groups like Susan G. Komen affiliates and patient-centered programs at Dana-Farber Cancer Institute and Fred Hutchinson Cancer Research Center.

Mission and Programs

Its mission aligns with clinical research priorities at centers including Cleveland Clinic, UCLA Health, University of Pennsylvania Health System, University of Chicago Medicine, and University of Michigan Health. Programmatic areas mirror trial consortia and scientific agendas promoted by entities such as American Society of Clinical Oncology, European Society for Medical Oncology, Society for Gynecologic Oncology, ASCO, and networks like the Gynecologic Oncology Group and the Translational Research Program at major cancer centers. Patient support services connect with survivorship programs at Memorial Sloan Kettering Cancer Center, UCSF Medical Center, Mount Sinai Health System, Stanford Health Care, and social support providers including American Red Cross affiliates and community health organizations.

Research Funding and Impact

Grantmaking targets basic, translational, and clinical research in collaboration with institutions such as Columbia University, Princeton University, Brown University, Duke University School of Medicine, Cornell University, Northwestern University Feinberg School of Medicine, University of California, San Diego, and University of Texas Southwestern Medical Center. Funded projects often intersect with precision medicine initiatives at Broad Institute, Salk Institute, Sloan Kettering Institute, Cold Spring Harbor Laboratory, and genomic programs at The Jackson Laboratory. Outcomes have influenced treatment guidelines issued by agencies like the Food and Drug Administration, recommendations from Centers for Disease Control and Prevention, and clinical practice at hospitals such as Beth Israel Deaconess Medical Center and Emory Healthcare.

Advocacy and Public Policy

Advocacy efforts engage lawmakers and policy staff connected to bodies like the United States Congress, Senate Committee on Health, Education, Labor, and Pensions, House Committee on Energy and Commerce, and executive agencies including the Department of Health and Human Services and National Institutes of Health. Policy campaigns have coordinated with coalitions featuring organizations such as American Cancer Society Cancer Action Network, Stand Up To Cancer, Cancer Research UK, Canadian Cancer Society, and patient advocacy groups across states like California, New York (state), Texas, Florida, and Pennsylvania. The organization has worked with foundations and research funders like the Wellcome Trust, Robert Wood Johnson Foundation, and state health departments to influence funding priorities and access to clinical trials at university systems including University of California, SUNY Downstate Health Sciences University, and Rutgers Biomedical Health Sciences.

Fundraising and Events

Fundraising initiatives include signature events and campaigns modeled after philanthropic events run by organizations such as Dana-Farber Cancer Institute galas, American Cancer Society Relay For Life, charity runs organized by New York Road Runners, and virtual fundraising models similar to those used by St. Jude Children's Research Hospital. Major events have drawn participation from corporate partners and donors associated with Goldman Sachs, JPMorgan Chase, Pfizer, Novartis, Roche, AstraZeneca, and Merck & Co.. Collaborations with media outlets and personalities have mirrored partnerships made by charities with broadcasters like NBC, ABC, CBS, and streaming platforms used by cultural institutions such as Broadway Cares/Equity Fights AIDS.

Governance and Partnerships

Governance structures reflect nonprofit best practices found in organizations like Bill & Melinda Gates Foundation, The Rockefeller University, Carnegie Corporation of New York, and university-affiliated research foundations. Boards and scientific advisory committees include leaders from medical schools such as Perelman School of Medicine at the University of Pennsylvania, Vanderbilt University Medical Center, Icahn School of Medicine at Mount Sinai, Weill Cornell Medicine, and research institutes like Scripps Research. Strategic partnerships extend to international consortia and public–private collaborations involving World Health Organization, European Commission, International Agency for Research on Cancer, OECD, and global cancer networks including Union for International Cancer Control.

Category:Medical and health organizations